Genome sequencing has also revealed the presence of metabolic mutations in patients with myelodysplastic syndromes (MDS) and AML related to the isocitrate dehydrogenase (IDH) 1 and IDH2 genes [36]. This evidence concerns the gene IDH2 and myelodysplastic syndrome.